Therefore, we suggest that LPL agonist may play a protective role in AF by accelerating the hydrolysis of TRLs, reducing the deposition of lipids in vascular endothelial cells, and reducing the activation and inflammatory response of endothelial cells. Here, LPL is linked to atrial fibrillation.